On Saturday, 7 November, a public health campaign titled ‘All for Him’ was held in Ban Jelačić Square in Zagreb, organised by the Croatian Society of Prostate Cancer Patients. The main aim of the initiative was to raise awareness of the importance of men’s health, with a particular focus on timely care for the prostate.
During the event, visitors had the opportunity to speak with experts in urology and oncology. The discussions focused on early diagnosis and treatment options for prostate cancer, the most commonly newly diagnosed malignant disease in men in Croatia, with around 2,800 new cases annually.
In addition to professional advice, citizens could collect informational materials and patient guides, as well as listen to personal accounts from those affected. A traditional part of the campaign was the roasting of chestnuts, the symbol of the initiative, as the prostate is often called a chestnut due to its shape and size.
Velimir Korak, president of the Croatian Society of Prostate Cancer Patients, thanked everyone who participated in the campaign – citizens, doctors, health professionals and patients. He emphasised the importance of timely discussion about prostate health and urged men not to wait for symptoms, but to regularly attend preventive check-ups.
As part of advances in treatment, radioligand therapy with 177lutetium-PSMA-617 will be available at the Zagreb University Hospital (KBC Zagreb) from December, intended for patients with metastatic castration-resistant prostate cancer who are positive on PSMA PET/CT scans. A special multidisciplinary team has been established for the application of this therapy. The VISION study showed that the therapy can reduce the risk of death by 38 per cent, alleviate symptoms and pain by around 55 per cent, and significantly lower PSA marker values in almost half of patients.
The Croatian Society of Prostate Cancer Patients has also launched a new website, zdravaprostata.hr, where detailed information on prostate cancer and available treatment options can be found.
